Blood Pressure Treatment Targets in Adults with Hypertension: A Guideline Topline
This guideline topline summary of recommendations for treating hypertension in adults is adapted from the American Academy of Family Physicians clinical guideline.
CDC 2023 Immunization Updates for 5 Vaccine-Preventable Illnesses
See highlights of CDC 2023 immunization updates for: pneumococcal disease; measles, mumps, and rubella; hepatitis B; polio; and monkeypox.
5 Questions on CDC Updates to COVID-19 and Flu Vaccine Guidance
Updates to CDC recommendations on influenza and COVID-19 vaccines and vaccine formulations will impact your choices during flu season this year.
Updated CDC Immunization Guidelines for 2023-2024 Tripledemic Viruses
CDC immunization recommendations for influenza, COVID-19, and RSV from the updated 2023 schedules are summarized in this Guideline Topline.
When Statin Guidelines Collide: 5 Questions on 2 Approaches to Primary CVD Prevention
Guidelines on primary ASCVD prevention from the USPSTF and the AHA/ACC/Multisociety differ on why and when to initiate a statin. Try the 5-question quiz.
Choosing Between Guidelines: Statins for Primary CVD Prevention
In a recent comparison of guideline recommendations for initiating statin therapy in primary prevention, researchers found significant differences in the numbers who would benefit.
7 Questions on Managing Patients with Diabetes at High Risk of Hypoglycemia
Try this 7-question quiz on the 2023 guidelines from The Endocrine Society that focus on advances in diabetes treatment that help minimize risk of hypoglycemia.
Endocrine Society Recommendations on How to Avoid Hypoglycemia in Patients with Diabetes: A Guideline Topline
The Endocrine Society's first update on management of hypoglycemia since 2009 emphasizes the value of new technology and therapeutics in minimizing risk.
ACP 2023 Guideline on Pharmacologic Treatment of Osteoporosis: A Guideline Topline
The updated American College of Physicians osteoporosis treatment guideline is summarized in this topline review for primary care clinicians.
Fluvoxamine and Inhaled Budesonide: Novel Combination Reduced Incidence of Severe COVID-19
When combined, fluvoxamine and inhaled budesonide appear more likely than either agent alone to reduce risk of early COVID-19 becoming severe, say TOGETHER investigators.
VA-DoD 2022 Recommendations on Use of Opioids for Management of Chronic Pain: A Guideline Topline
Updated VA/DoD chronic pain management guidelines include recommendations for dual use of buprenorphine and increased mental health assessment before prescribing opioids.
VA-DoD Guidelines on Opioids for Chronic Pain Recommend Dual Role for Buprenorphine
New pain management guidelines suggest use of buprenorphine as a potentially "safer" opioid analgesic for chronic pain when there are no reasonable alternatives.
SGLT2 Inhibitor Reduces CV, Renal Events in Type 2 Diabetes
ADA 2019-Dapagliflozin reduced CV death, hospitalization for HF, and progression of CKD among T2DM patients with a wide distribution of baselines CVD risk in DECLARE-TIMI 58.
Are Abuse-deterrent Opioids Working?
Four studies presented at PAINWeek 2016 review the success of abuse-deterrent opioid formulations in stemming abuse and non-medical use.
Depression Increases Risk of Stroke
